Internal Medicine
Endocrinology
Neck Mass, Goiter, Thyroid Disease

Neck Mass Goiter Thyroid Disease

Introduction

Welcome to the comprehensive MCCQE1 study guide on Neck Mass Goiter Thyroid Disease. This resource is tailored for Canadian medical students preparing for the Medical Council of Canada Qualifying Examination Part I (MCCQE1). We'll cover essential concepts, Canadian guidelines, and provide practice questions to help you succeed in your exam and future medical practice in Canada.

🇨🇦

This guide is specifically designed for the Canadian healthcare context and MCCQE1 exam preparation. Pay close attention to Canadian-specific guidelines and epidemiology throughout this resource.

Table of Contents

  1. Anatomy and Physiology
  2. Types of Thyroid Disease
  3. Goiter Classification
  4. Clinical Presentation
  5. Diagnostic Approach
  6. Management
  7. Canadian Guidelines
  8. Key Points to Remember for MCCQE1
  9. Sample MCCQE1 Question
  10. References

Types of Thyroid Disease

For MCCQE1 preparation, it's essential to understand the various thyroid disorders prevalent in the Canadian population.

Causes:

  • Graves' disease (most common in Canada)
  • Toxic multinodular goiter
  • Toxic adenoma

Symptoms: Weight loss, heat intolerance, palpitations, anxiety

Clinical Presentation

Recognizing the clinical presentation of thyroid disorders is essential for MCCQE1 preparation and patient care in Canada.

Step 1: Patient History

  • Ask about family history of thyroid disorders (common in Canada)
  • Inquire about symptoms of hyper- or hypothyroidism
  • Assess for compressive symptoms (dysphagia, dyspnea)

Step 2: Physical Examination

  • Inspect the neck for visible enlargement or asymmetry
  • Palpate the thyroid gland for size, consistency, and nodules
  • Check for signs of thyroid dysfunction (e.g., exophthalmos, bradycardia)

Step 3: Associated Symptoms

  • Look for systemic signs of thyroid dysfunction
  • Assess for lymphadenopathy
  • Evaluate for signs of compression (e.g., stridor, venous distension)

Management

Management of thyroid disorders in Canada follows evidence-based guidelines and considers the unique aspects of the Canadian healthcare system.

Hyperthyroidism Treatment

  1. Antithyroid Medications:

    • Methimazole (preferred in Canada)
    • Propylthiouracil (second-line due to hepatotoxicity risk)

  2. Radioactive Iodine Therapy:

    • Commonly used in Canada for definitive treatment
    • Requires proper patient education and follow-up

  3. Surgery (Thyroidectomy):

    • Indicated for large goiters, suspected malignancy, or patient preference
    • Performed by experienced endocrine surgeons in Canadian hospitals

Hypothyroidism Treatment

  • Levothyroxine replacement therapy
  • Regular monitoring of TSH levels
  • Dose adjustments based on clinical response and lab results

Thyroid Nodules and Cancer

  • Active surveillance for low-risk nodules
  • Surgery for suspicious or confirmed malignant nodules
  • Post-operative radioiodine therapy for specific thyroid cancer types
📊

MCCQE1 Focus: Be familiar with the Canadian Thyroid Cancer guidelines, as management may differ slightly from international standards.

Key Points to Remember for MCCQE1

  1. 🇨🇦 TSH is the primary screening test for thyroid dysfunction in Canada
  2. 🏥 Graves' disease is the most common cause of hyperthyroidism in Canadian patients
  3. 🧪 Hashimoto's thyroiditis is the leading cause of hypothyroidism in Canada
  4. 📏 Know the size criteria for FNA biopsy of thyroid nodules according to Canadian guidelines
  5. 💊 Methimazole is the preferred antithyroid medication in Canada
  6. 🧂 Iodine deficiency is rare in Canada due to mandatory iodization of salt
  7. 🩺 Understand the CanMEDS roles in managing thyroid disorders, especially patient advocacy and communication

References

  1. Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., ... & Woeber, K. A. (2012). Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid, 22(12), 1200-1235.

  2. Burch, H. B., Cooper, D. S., Garber, J. R., & Greenlee, M. C. (2019). Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocrine Practice, 25(1), 82-83.

  3. Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., ... & Wartofsky, L. (2016). 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid, 26(1), 1-133.

  4. Canadian Thyroid Cancer Guidelines 2020. Canadian Journal of Surgery. Link (opens in a new tab)

  5. Toward Optimized Practice (TOP) Endocrine Working Group. (2014). Investigation and management of primary thyroid dysfunction clinical practice guideline. Edmonton, AB: Toward Optimized Practice.

  6. Public Health Agency of Canada. (2019). Canadian Chronic Disease Surveillance System (CCDSS), Thyroid Disease Data Tool. Link (opens in a new tab)

  7. Royal College of Physicians and Surgeons of Canada. (2015). CanMEDS: Better standards, better physicians, better care. Link (opens in a new tab)

HypokalemiaGlucose Abnormalities